Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma



Status:Recruiting
Healthy:No
Age Range:Any
Updated:4/21/2016
Start Date:December 2011

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Observational - CRKL Expression at the Protein Level in Rhabdomyosarcoma Tumors by Tissue Microarray (TMA)

This research trial studies biomarkers in tumor tissue samples from younger patients with
rhabdomyosarcoma. Studying samples of tumor tissue from patients with cancer in the
laboratory may help doctors learn more about changes that occur in DNA and identify
biomarkers related to cancer

PRIMARY OBJECTIVES:

I. To demonstrate CRKL expression at the protein level in rhabdomyosarcoma tumors by tissue
microarray (TMA).

OUTLINE:

Archived tumor tissue samples are analyzed for CRKL expression.

Inclusion Criteria:

- Alveolar rhabdomyosarcoma and embryonal rhabdomyosarcoma specimens from the Children
Oncology Group (COG) tumor microarrays (TMAs)
We found this trial at
1
site
Children's Oncology Group
Monrovia, California 91016
Principal Investigator: Lee J. Helman, MD
Phone: 301-496-4256
?
mi
from
Monrovia, CA
Click here to add this to my saved trials